We also noted that high BMP4 exerted a selective suppressive effect on metastatic disease without impacting behaviour of the primary tumour, suggesting that the anti-metastatic pathways governed by BMP4 might have substantial relevance to metastatic cancer control in the clinic. The gene discussed is BMP4; the disease is metastatic malignant neoplasm.